Highlights Mycenax Biotech Inc.

Equities

4726

TW0004726005

End-of-day quote Taipei Exchange Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
45 ^TWD	+4.05%		+6.38%	+26.05%

05-15	Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-14	Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/08/22	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/05/22	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	14/08/21	CI
Mycenax Adapts the Beacon Optofluidic System to Cell Line Development Services	18/05/21	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	16/05/21	CI
Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	29/03/21	CI
Mycenax Biotech Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	11/11/20	CI
Mycenax Biotech Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/08/20	CI
Mycenax Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	12/05/20	CI
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. agreed to acquire Biosimilar Tocilizumab from Mycenax Biotech Inc. for TWD 19.5 million.	28/04/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mycenax Biotech Inc.

Equities

4726

TW0004726005

Highlights

Filters